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INTRODUCTION 
Impaired carbohydrate tolerance is a common accompaniment of diabetic 
ketoacidosis (1) and chronic renal failure (2). Common to both these states 
is the presence of metabolic acidosis. Although several previous animal 
(3-5) and in vitro (6-8) studies have suggested that acidosis per se may 
result in an impairment of glucose metabolism, such an effect has not been 
well studied in man and the mechanism(s) by which acidosis impairs glucose 
metabolism have not been defined. 
Haldane et.al. (9) were the first to examine the effect of metabolic 
acidosis on glucose metabolism in man. Following the injestion of ammonium 
chloride they found an impairment of glucose tolerance which persisted for 
some time following the return of blood pH to normal. Walker et.al. (6) 
noted decreased sensitivity to exogenously administered insulin in six 
diabetics with ketoacidosis (blood pH <7.20) and improvement in insulin 
sensitivity following correction of the acidosis. However, these authors 
could not exclude other changes in the diabetic state as responsible for the 
improvement in insulin sensitivity. In the only other study in man, Baird 
(10) was unable to demonstrate any adverse effect of ammonium chloride induced 
acidosis on the intravenous glucose tolerance test. However, all of his 
subjects were treated with quinalbarbitone prior to study and this could have 
obscured any differences between the control and ammonium chloride treated 
groups. 
Mackler et.al. examined the effect of ammonium chloride induced metabolic 
acidosis (mean blood pH and serum bicarbonate concentration = 7.06 and 6 mEq/L) 
in dogs (3-5). They found a consistent increase in fasting glucose concentra¬ 
tion, a blunted response to exogenous insulin, and impairment in the intra¬ 
venous glucose tolerance test. They also observed a failure of the normal 

decline in serum potassium and phosphate concentration (11-14) in response 
to both insulin and glucose, again suggesting impaired sensitivity to the 
action of insulin. However, the interpretation of the above studies is 
obscured by the fact that the dogs were also fasted over the three days 
during which the metabolic acidosis was induced. Thus, it is difficult to 
differentiate an effect of acidosis versus fasting on the decline in glucose 
tolerance. In the only other study performed in dogs, Deuel and Gulick were 
unable to demonstrate an effect of ammonium chloride-induced acidosis on 
carbohydrate tolerance (15). In vitro studies employed the rat epididymal fat 
pad (6), the rat hemidiaphragm (6,8), and circulating erythrocytes and 
leukocytes (5,7) have also suggested that acidosis inhibitsglucose uptake 
and oxidation. 
To examine the effect of metabolic acidosis on glucose metabolism and 
to define the relative contributions of impaired insulin resistance, 
imparied beta-cell secretion of insulin, and augmented hepatic qlucose oroduction 
to the carbohydrate intolerance, we studied 12 subjects with the glucose 
clamp technique before and after the induction of chronic metabolic with 
ammonium chloride. 
METHODS 
A. Subjects: (Table I). Twelve healthy volunteers ranging in age 
from 22 to 31 were studied. They were evenly divided between males and 
females and all were within 20% of their ideal body weight. The middle 
of the weight range for subjects of medium frame from the 1959 Metropolitan 
Life Insurance Company table for desirable weight was used to determine ideal 
body weiqht. All subjects were consuming a weight maintainina diet containing at 
least 200 gms of carbohydrate per day for 3 days prior to study. Other than subjec 

M.K., M.D. and M.S., who were on oral contraceptives, subjects consumed 
no other medications for at least two weeks prior to study. There was 
no family history of diabetes. A total of 24 studies were performed on 
the 12 subjects. All subjects were studied at 8 a.m. following a twelve 
hour overnight fast. Following the initial study each subject received 
ammonium chloride in a dose of either 0.1 or 0.15 gm/kg of body weight 
per day for three days and the study was repeated on the morning of the 
fourth day. Each subject thereby served as his own control. The ammonium 
chloride was administered in divided doses every 6 hours with the last dose 
being given at 11 p.m. on the evening prior to study. Although two subjects 
complained of mild abnormal discomfort, there was no vomiting and all 
continued on the diet as stated above. 
Prior to each study a polyethylene catheter was inserted into an 
anticubital vein under local xylocaine anesthesia for administration of all 
test substances. A second catheter was inserted into a hand vein for blood 
sampling. The hand was then inserted into a heated chamber in which the 
air temperature was maintained at 70±2 degrees centigrade. This was done 
to insure arteriolization of venous blood (16). 
B. Hyperglycemic Clamp: After a control period of at least thirty 
minutes a priming infusion of glucose designed to rapidly raise the blood 
glucose concentration to 125 gm/dl above the fasting level was administered 
in a logarithmically falling manner over 15 minutes. Arteriolized venous 
blood was sampled every two minutes for the first ten minutes to quantitate 
the early releasable insulin peak. Thereafter, blood samples were drawn 
every five minutes for 110 minutes. The plasma glucose concentration was 
rapidly determined (analytical delay was less than two minutes) on each sample 
and the infusion rate of a 20% glucose solution was adjusted to maintain the blood 

glucose concentration constant at 125 mg/dl above the basal level. The 
formula for the servo-correction is based upon the negative feedback 
principle. Thus, if the actual plasma glucose concentration is greater 
than the goal, the glucose infusion rate is decreased and vice-versa. Of 
pertinence to this paper is the fact that the actual plasma glucose 
concentration was maintained within narrow limits of the specified goal 
(see Results). Under these steady-state conditions of constant hyperglycemia 
the amount of glucose infused (mg/kg of body weight/min) minus urinary losses 
(mg/kg of body weight/min) is a measure of the glucose metabolized, M. 
Although the clamp method does essentially eliminate variance from subject 
to subject in blood glucose concentration, the plasma insulin levels are not 
the same in all subjects. In the euglycemic clamp (see below), insulin 
levels vary only as a function of its metabolic clearance rate (MCR). In 
the hyperglycemic clamp insulin levels vary not only as a function of MCR, 
but also on a function of the sensitivity of the beta cell to hyperglycemia. 
The fact that insulin levels vary makes it essential to correct the value 
for M in some manner to take this variance into account. The simplest 
technique is to compute the ratio of M to the plasma insulin level, I, that 
is, to compute M/I. The underlying mathematical assumptions of such a 
computation are that M is linearly related to I and that there is no intercept 
of M on I. If either of these two assumptions is incorrect, then a more 
complex formulation would be required. For example, computation of an M/log I 
might be justified. We have chosen to correct for the insulin concentration 
by the simplest possible technique, M/I. The mean insulin concentration in 
the 24 euglycemic and hyperglycemic clamp studies is 104 uU/ml (Tables 2 and 3) 
with a standard deviation of ±32. Within these reasonably narrow limits it 
is doubtful whether more complex formulations would significantly change the 
conclusions presented. 

C. Euglycemic Clamp: A prime plus continuous infusion of crystalline 
porcine insulin (Eli Lilly Co., Indianapolis, In.) was administered to obtain 
constant hyperinsulinemia (17). The primary dose was administered in a 
logarithmically falling manner over ten minutes at which time the continuous 
insulin infusion was begun. The total amount of insulin infused during the 
priming period was twice that infused during subsequent ten minute intervals. 
p 
The continuous infusion (40 mU/m surface area per min) was maintained for 
110 minutes. In order to prevent insulin adsorption to glassware and to 
the plastic infusion apparatus, infusates were prepared with the addition of 
2 ml of the subject's whole blood per 50 ml of infusate. Hypoglycemia with 
its attendant counter-regulatory responses was prevented by the glucose clamp 
technique (see under hyperglycemic clamp) which was used to maintain each 
subject at his own basal blood glucose concentration during insulin 
administration. The initial glucose infusion rate was 2.0 mg/kg body weight/ 
min and was started four minutes after the insulin infusion was begun. At 
ten minutes the glucose infusion was increased to 3.0 mg/kg/min; these doses 
were empirically determined. The first servo-correction was made at 14 
minutes. Under the condition of constant euglycemia all of the glucose 
infused (M) is metabolized and is thus a measure of the body's sensitivity 
to insulin. During the euglycemic clamp the effect of insulin on hepatic 
glucose production was examined with tritiated glucose labeled in the 3 
position ([%]glucose). For 3 hours prior to beginning the insulin infusion, 
each subject's glucose pool was labeled by a primed continuous infusion of 
[^T] glucose. The labeled glucose was administered as an initial intravenous 
priming dose followed immediately by a continuous intravenous infusion at a 
rate of about 0.25 uCi/min. Plasma samples for determination of glucose 
specific activity were taken at 30 minute intervals for the first two hours 
and at 15 minute intervals for the subsequent hour. A steady state plateau 

glucose specific acticity was achieved in all subjects during the third 
hour of [3t] glucose infusion and this plateau value was used to calculate 
basal hepatic glucose production. After 3 hours of continuous [^T] glucose 
infusion, the euglycemic clamp was begun as previously described and the 
continuous infusion of [~T] glucose was continued at the same rate. During 
the clamp study plasma samples for glucose specific activity were drawn 
every 15 minutes. Three control samples for amino acids and glucagon were 
obtained prior to beginning both the euglycemic and heperglycemic clamp 
studies; subsequent samples were drawn at 15-30 minute intervals. 
D. Calculations: Hyperglycemic Clamp: The fasting plasma insulin 
concentration, the early (0-10 minute), late (20-120 min), and total plasma 
insulin (I) responses, the amount of glucose metabolized (20-120 minute time 
period) and the M/I ratio (a measure of tissue sensitivity to insulin) were 
compared before and after NH^l loading. The basal glucagon and amino acid 
levels as well as the change in plasma glucagon and amino acid concentrations 
following glucose were also compared before and after NH4C1 loading. 
Euglycemic Clamp: Tissue sensitivity to insulin (M/I ratio during time 
= 20-120 minutes) and the metabolic clearance rate (MCR) of insulin were 
compared before and after ammonium chloride loading. The MCR of insulin was 
calculated by dividing the insulin infusion rate by the steady state plasma 
insulin concentration during the 40-120 minute time period minus the basal 
insulin concentration. Plasma glucagon and amino acid concentrations were 
analyzed as described above for the hyperglycemic clamp. Basal hepatic 
glucose production before and after ammonium chloride loading was determined 
3 
by dividing the [ T] glucose infusion rate (counts/min) by the steady state 
plateau of [ T] glucose specific activity during the last hour of the control 
period. Following insulin-glucose administration (euglycemic clamp) a non¬ 
steady state condition in glucose specific activity exists and hepatic glucose 

production was approximately using the Steele equations (equations 4A and 
5A, reference #18) average values for the rates of glucose turnover for the 
intervals between two conservative sampling times. 
All data are presented as the mean - SEM. Statistical significance 
between the difference of two means was calculated by paired T-test analysis. 
E. Analytical Procedures: Plasma glucose analyses were performed 
in duplicate on arterized venous samples using the glucose oxidase method 
(Glucostat, Beckman Instruments Corp., Fullerton, Ca. 92634). Insulin was 
determined by radioimmunoassay with talc to separate bound from free insulin 
(19). Plasma glucagon was analyzed by radioimmunoassay with Unger antibody 
30K (20). For determination of amino acids, plasma proteins were removed by 
precipitation with sulfosalicylic acid (21). Amino acids were then determined 
by automated ion exchange chromatography (22) with a Beckman 120C amino acid 
analyzer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Ca.) modified 
for single column analysis of basic as well as acidic and neutral amino acids 
(23). 
For determination of [^T] glucose specific activity, plasma samples were 
centrifuged immediately and plasma deproteinized using ZnS04 and Ba (0H)2 (24). 
The filtrates were analyzed for glucose content by the glucose oxidase method 
as previously described. Aliquots (0.5 ml) of plasma filtrates were then 
evaporated to dryness in counting vials in a partial vacuum at 70°C to eliminate 
metabolic T2O. The dried residues were redissolved in one ml of water, to 
which 10 ml of aquasol was added for counting (Packard Model 3003 Tri-Carb 
Liquid Scintillation Spectrometer, 78% efficiency, with internal quenching). 

RESULTS 
Hyperglycemic clamp: Prior to NH^Cl the fasting blood glucose 
concentration averaged 94-3 mg/dl. Durino the period of sustained 
hyperglycemia the mean glucose concentration of the five subjects 
was 215-4 ma/dl. Following NH^Cl the fastina blood glucose and 
steady state hyperglycemic levels averaged 92-1 mq/dl and 218-1 mg/dl 
respectively. The stability of the blood glucose concentration during the 
period of hyperglycemia is shown by the coefficient of variation which 
averaged 3.9-0.61 during the control studies and 3.6-0.7% post NH4CI. 
The amount of glucose metabolized (M) during the hyperalvcemic 
clamp decreased from 9.09 ma/kg body wt./min. to 7.43 mg/Kq body wt./min. 
followina NH4CI (p<0.10. Table 2). The fasting plasma insulin 
concentration in the 12 subjects following NH4CI (17-1 yU/ml) was 
significantly hiqher than during the control study (13 - 1 yU/ml, p 0.02). 
Following the creation of a square wave plateau of hyperglycemia, the 
plasma insulin response was biphasic with an early burst of insulin 
within the first six minutes followed by a gradually increasing phase of 
insulin release that lasted until the end of the study. There was no 
difference in the early insulin response (0-10 min.) between the control 
and NH4C1 studies (Table 2, Figure 1). However, the late insulin response 
(10-120 min.) tended to be greater following the induction of metabolic 
acidosis and the plasma insulin concentration was statistically significantly 
higher during the 10-60 minute period. Tissue sensitivity to insulin 
(M/I ratio) post NH^Cl decreased in all five subjects by an average of 
32-6% (Table II, p<0.02). 
The fastina plasma alucaaon concentration in the twelve subjects 
following NH4CI was significantly higher than during the control study 

(110 ± 18 pa/ml versus 95 - 17 pg/ml, p<0.01). Followinq the creation 
of a steady state plateau of hyperglycemia, plasma olucagon concentration 
was suppressed similarly in both the pre and post NH4CI studies (Figure 2). 
Euglycemic Clamp (Table 3). 
The prime-continuous insulin infusion resulted in a steady state 
plasma insulin level (10-120 minutes) that averaoed 114 - 4 yli/ml during 
the control study and 110-6 yll/ml following the induction of metabolic 
acidosis with NH4CI (Fiqure 3). The stability of the plasma insulin 
concentration is shov/n by the coefficient of variation which averaoed 
9-1% durina the control study and 10 - 1% followinq NF^Cl. There was no 
difference in the metabolic clearance rate of insulin (insulin infusion rate 
divided by the increase above basal in the 40-120 minute insulin 
concentration) between the control (415 - 23 ml/min./M2) and acidotic 
(412 - 27 ml/min/M^) studies. 
The fastina plasma glucose concentrations during the control and 
NH4CI studies were 91-2 mg/dl and 88 - 1 mo/dl. During the period of 
hyperinsulinemia, the plasma alucose concentration was held constant 
at the basal level with a mean coefficient of variation of 4.7 - 0.4% 
and 4.2 - 0.3% respectively. 
The amount of glucose metabolized following NH4CI decreased from 
7.13 - 0.77 to 6.15 - 0.54 mo/kg body wt/min (p=0.07) and the M/I ratio 
declined from 6.33 - 0.60 to 5.61 - 0.^5 in units of (mg/kq/min per yU/ml) 
X 100 (p<0.10). 
Followinq the infusion of insulin and olucose, plasma olucaoon 
suppressed normally during the control study (p<0.01, figure 4). 

Following the induction of metabolic acidosis with NH^Cl, the suppression 
of glucagon by insulin and glucose was less complete, becoming statistically 
significantly different at only the 105 and 120 minute values. Plasma 
amino acid concentrations were measured in subjects M.K., A.P., and M.S. 
No difference in fasting levels were observed between the control and 
NH4CI studies. Following the creation of hyperinsulinemia, a decrease 
in the levels of valine, leucine, isoleucine, phenylalanine, threonine, 
tyrosine, methionine, and serine was observed. 
DISCUSSION 
Previous studies examining the effect of metabolic acidosis on 
glucose metabolism have yielded conflicting results. Several reports 
have suggested that ammonium chloride-induced metabolic acidosis results 
in an impairment of the intravenous glucose tolerance test and decreased 
tissue sensitivity to exogenous insulin (3-6). However, several 
investigators have failed to find a decrease in glucose tolerance (10,15) 
and the plasma insulin response to glucose following metabolic acidosis 
has not been reported. 
In the present study we employed the glucose clamp technique to 
examine the relative contributions of impaired beta cell secretion of 
insulin versus tissue insensitivity to insulin in the genesis of the glucose 
intolerance following chronic ammonium chloride induced metabolic acidosis. 
This technique offers several advantages over the usual techniques employed to 
assess glucose metabolism: 
(1) During the hyperglycemic clamp the glucose stimulus presented to the 
beta cell is controlled; thus, repeat studies of beta cell sensitivity 
can be accurately interpreted and compared before and after induction of 

metabolic acisosis. Furthermore, since the glucose stimulus is 
presented as a square wave one can examine the early and late phases 
of insulin secretion independently. 
(2) In both the hyperglycemic and euglycemic clamps, the plasma 
glucose concentration is held constant. Consequently, the amount of 
glucose infused must equal the amount of glucose metabolized by all the 
tissues of the body (minus urinary glucose losses) and thus allows 
quantitation of the glucose metabolized. 
(3) The euglycemic clamp offers major advantages over the insulin 
tolerance test in assessing insulin sensitivity, since the basal glucose 
concentration is maintained, thereby avoiding the complex neuro-endocrine 
response to hypoglycemia. The test thus provides a purer estimate of 
sensitivity to insulin. 
(4) Tissue insensitivity to insulin could reside in peripheral 
tissues (muscle, adipose) or in the liver. By performing the 
euglycemic clamp in combination with [^T] glucose the contribution of 
increased hepatic glucose production to the observed insulin resistance 
can be determined. 
(5) The hyperglycemic and euglycemic clamps provide independent 
tests of the sensitivity of the body to endogenously-released and to 
exogenously-administered insulin. 
The results of the hyperglycemic and euglycemic clamps clearly 
demonstrate that metabolic acidosis results in the impairment of glucose 
tolerance and that the effect of acidosis is mediated via decreased sensitivity 
to insulin. During the hyperglycemic clamp, a decline in glucose 
metabolism was observed despite a 26% increase in the plasma insulin 
response. Consequently, the M/I ratio (a measure of tissue sensitivity 

to insulin) fell significantly in all five subjects by an average of 
32% (p<0.02). The presence of insulin resistance is also suggested 
by the elevated fasting insulin levels in the face of normal glucose 
concentrations. 
Seven subjects also received a euglycemic clamp study to provide an 
independent measure of tissue sensitivity to insulin. Tissue sensitivity 
to insulin declined in 6 of the 7 by an averaae of 1 2%. When the 
results of the euglycemic clamp are combined with those of the 
hyperglycemic clamp a hiahly significant decline (p<0.01) in tissue 
sensitivity to insulin following metabolic acidosis is observed. These 
results indicate that mild metabolic acidosis (mean decline in blood pH and 
serum bicarbonate concentration = 0.04 and 4 mE q/L respectively) results 
in decreased glucose tolerance which is mediated via tissue insensitivity 
to insulin. Beta cell sensitivity to olucose is not affected and insulin 
secretion is augmented in an attempt to overcome this insulin resistance. 
It is likely that more severe dearees of metabolic acidosis which are 
maintained for longer periods of time will result in even areater insulin 
resistance. Attempts to administer ammonium chloride loads nreater than 
0.15 grams/kg body wt/day in human subjects were poorlv tolerated and 
the effect of more severe acidosis on olucose metabolism could not be 
examined. 
The studies with [^T]-qlucose suooest that the insulin resistance 
resides in the periphery rather than with the liver. Prior to the 
administration of NH^Cl, basal hepatic glucose production averaaed 1.85 
mg/kg/min. Following NH^Cl basal glucose production was unchanged.(Table V). 
Thus, unlike ranal gluconeoaenesis which is stimulated bv metabolic 
acidosis (25), hepatic glucose production appears to be unaffected. 
Although these results exclude augmented basal hepatic olucose production 

as the cause of the observed insulin resistance, it is still 
possible that incomplete suppression of glycogenolysis and/or 
gluconeogenesis by insulin is responsible for the decline in glucose 
tolerance. The answer to this question awaits final completion of the 
pT] glucose data. Although basal plasma glucagon levels were mildly 
elevated following NH4CI, it is unlikely that such a small increase 
could have any significant effect in augmenting hepatic glucose production 
on a sustained basis (26). Furthermore, both hyperinsulinemia and 
hyperglycemia resulted in normal glucagon suppression in the presence 
of systemic acidosis. 
It is well known that insulin lowers the systemic concentration 
of certain amino acids, most notably valine, leucine, isoleucine, 
methionine, tyrosine, and phenylalanine (27). This effect of insulin 
appears to be the result of net inhibition of amino acid output from 
muscle (28). To examine whether the insulin resistance observed with 
glucose metabolism also extends to amino acid metabolism, we measured 
the fall in circulating amino acids during the euglycemic clamp studies 
in three subjects. Following the administration of insulin a prompt 
decline in plasma valine, leucine, isoleucine, methionine, tyrosine, 
phenylalanine, and serine was observed in all subjects both before and 
after NH4Cl.*Thus, it appears that the insulin resistance observed 
following the induction of metabolic acidosis is specific for 
carbohydrate metabolism. 
* TABLE IV 

SUMMARY: 
The effect of metabolic acidosis on glucose metabolism was examined 
in 12 healthy volunteers employing two types of glucose clamp experiments. 
Each subject was studied before and after the ingestion of 0.1 gm of ammonium 
chloride per kg body wt. per day for three days. For all subjects, the fasting 
insulin concentration rose significantly without change in the fasting glucose 
concentration. 
Hyperglycemic clamp: The plasma glucose concentration is acutely raised 
and maintained at 125 mg/dl above the fasting level for two hours by the 
periodic adjustment of a variable glucose infusion. Since the glucose 
concentration is held constant, the glucose infusion rate is on index of glucose 
metabolism (M). Following ammonium chloride M declined from 9.09 to 7.43 mg/kg 
body wt/min (p=0.10) despite a rise in plasma insulin response. Consequently, 
the M/I ratio, an index of tissue sensitivity to endogenous insulin, declined 
in all subjects by 35% (p<0.005). 
Euglycemic clamp: The plasma insulin concentration is acutely raised 
approximately 100 U/ml above basal levels and is maintained by a prime- 
continuous insulin infusion. The blood glucose concentration is held constant 
by a variable glucose infusion. M/I is again a measure of time sensitivity to 
exogenous insulin and fell by 10% (p=0.09). A normal decline in plasma amino 
acids value, leucine, isoleucine, methionine, tyrosine, phenylalanine, and serine 
was observed both before and after the induction of metabolic acidosis. 
Both the hyperglycemic and euglycemic clamp techniques demonstrate tissue 
insensitivity to insulin following NH4CI induced metabolic acidosis. The 
tissue resistance to insulin is specific for glucose metabolism and does not 
extend to amino acid metabolism. 
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Legend to Figures 
Figure 1. 
Figure 2. 
Figure 3. 
Figure 4. 
The time course of the mean plasma insulin concentration 
during the hyperglycemic clamp in normal subjects pre ( © ) 
and post (O ) ammonium chloride. The height of the bars 
represent the EM.*=P <0.05; **=P <0.02. 
The time course of the mean (-SEM) plasma glucagon concentration 
during the hyperglycemic clamp in normal subjects pre and 
post ammonium chloride. *=P< 0.005; **=P <0.05. 
The time course of the mean (*SEM) plasma insulin concentration 
during the euglycemic clamp in normal subjects pre arid post 
ammonium chloride. *=P< 0.05; **=P <0.02. 
The time course of the mean (-SEM) plasma glucagon 
concentration during the euglycemic clamp in normal subjects 
pre and post ammonium chloride. *=P <0.02; **=P <0,05. 
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